EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudie

Clinical Effectiveness of Transcatheter Left Atrial Appendage Occlusion With Watchman FLX Compared With First-Generation Watchman

Matthew J Price, Zhen Tan, Sarah Zimmerman, Jeptha P Curtis, James V Freeman

JACC: Cardiovascular Interventions · 2025

DOI: 10.1016/j.jcin.2025.03.025 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JACC: Cardiovascular Interventions, 2025. Verfasst von Matthew J Price und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Diseases, Scripps Clinic, La Jolla, California, USA. Electronic address: price.matthew@scrippshealth.org. Hauptthemen laut MEDLINE: Atrial Appendage, Atrial Fibrillation, Cardiac Catheterization. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Procedural complications, device-related thrombus, and peridevice leak may limit the benefit of transcatheter left atrial appendage occlusion (LAAO). Although next-generation devices incorporate design modifications meant to address these phenomena, the longer term impact of these modifications on outcomes has not been described. OBJECTIVES: The aim of this study was to compare 1-year safety and clinical effectiveness of the Watchman FLX with the predicate Watchman 2.5 device. METHODS: The National Cardiovascular Data Registry LAAO Registry was used to identify: 1) patients who received the Watchman FLX; and 2) an identical number of patients receiving the Watchman 2.5 at the same sites directly preceding the first Watchman FLX case at each site. The primary endpoint was ischemic stroke. A secondary analysis was performed using 2:1 propensity score matching. RESULTS: The study cohort consisted of 27,141 patients receiving each device. Among patients undergoing transesophageal echocardiography at 45 days, the rate of device-related thrombus was not different for Watchman FLX compared with Watchman 2.5 (0.4% vs 0.5%; P = 0.27) while the rate of any peridevice leak was significantly lower (14.7% vs 23.5%; P < 0.001). At 1 year, Watchman FLX was associated with a significantly lower risk for major adverse events (adjusted HR: 0.84; 95% CI: 0.80-0.88; P < 0.0001), ischemic stroke (adjusted HR: 0.82; 95% CI: 0.68-0.98; P = 0.02), and ischemic stroke or systemic embolism (adjusted HR: 0.74; 95% CI: 0.62-0.87; P = 0.0003). The findings of the propensity score matching analysis were similar. CONCLUSIONS: Transcatheter LAAO with the Watchman FLX is associated with significantly lower risks for major adverse events and ischemic stroke at 1 year compared with the predicate Watchman device. These findings suggest that enhanced procedural safety and completeness of anatomical closure translate into better longer term safety and clinical effectiveness after transcatheter LAAO.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial AppendageAtrial FibrillationCardiac CatheterizationAgedAged, 80 and overFemaleHumansMaleIschemic StrokeProsthesis DesignRegistriesRisk AssessmentRisk FactorsThrombosisTime FactorsTreatment OutcomeUnited StatesFollow-Up Studies

Stichwörter der Autor:innen

Watchmanatrial fibrillationbleedingleft atrial appendagepericardial effusionstroke

Autor:innen und Institutionen

  • Division of Cardiovascular Diseases, Scripps Clinic, La Jolla, California, USA. Electronic address: price.matthew@scrippshealth.org.
  • Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, Connecticut, USA.
  • Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, Connecticut, USA; Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.

Zitieren

APA

Price, M. J., Tan, Z., Zimmerman, S., Curtis, J. P., & Freeman, J. V. (2025). Clinical Effectiveness of Transcatheter Left Atrial Appendage Occlusion With Watchman FLX Compared With First-Generation Watchman. JACC: Cardiovascular Interventions. https://doi.org/10.1016/j.jcin.2025.03.025

Vancouver

Price MJ, Tan Z, Zimmerman S, Curtis JP, Freeman JV. Clinical Effectiveness of Transcatheter Left Atrial Appendage Occlusion With Watchman FLX Compared With First-Generation Watchman. JACC: Cardiovascular Interventions. 2025. doi:10.1016/j.jcin.2025.03.025

BibTeX
@article{Price2025,
  author = {Price, Matthew J and Tan, Zhen and Zimmerman, Sarah and Curtis, Jeptha P and Freeman, James V},
  title = {Clinical Effectiveness of Transcatheter Left Atrial Appendage Occlusion With Watchman FLX Compared With First-Generation Watchman},
  journal = {JACC: Cardiovascular Interventions},
  year = {2025},
  doi = {10.1016/j.jcin.2025.03.025}
}
Kostenlos starten →